Cardiac allograft vasculopathy following fecal microbiota transplantation for recurrent C. difficile infection

被引：6
|
作者：
Barfuss, Spencer [1 ]
Knackstedt, Elizabeth Doby [2 ]
Jensen, Kyle [2 ]
Molina, Kimberly [2 ]
Lal, Ashwin [2 ]
机构：
[1] Univ Utah, Primary Childrens Hosp, Pediat Residency Program, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pediat, Primary Childrens Hosp, Salt Lake City, UT USA
来源：
TRANSPLANT INFECTIOUS DISEASE | 2018年 / 20卷 / 06期
关键词：
cardiac allograft vasculopathy; CAV; clostridum difficile; fecal microbiota transplant; FMT; heart transplant;
D O I：
10.1111/tid.12983
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We report the case of a 3-year-old male who developed recurrent Clostridium difficile infection after receiving an orthotopic heart transplant. Despite multiple courses of antibiotics, C. difficile infection was persistent and he underwent a fecal microbiota transplant. The patient responded with resolution of his diarrhea. However, within 2 months he developed severe mixed rejection with high circulating donor-specific antibodies and significant coronary vasculopathy. Organ dysfunction led to the need for re-transplantation. The patient's postoperative course has since been complicated by pneumatosis intestinalis and recurrent C. difficile infection.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report
    Spinner, Joseph A.
    Bocchini, Claire E.
    Luna, Ruth A.
    Thapa, Santosh
    Balderas, Miriam A.
    Denfield, Susan W.
    Dreyer, William J.
    Nagy-Szakal, Dorottya
    Ihekweazu, Faith D.
    Versalovic, James
    Savidge, Tor
    Kellermayer, Richard
    PEDIATRIC TRANSPLANTATION, 2020, 24 (01)
  • [32] Short-Chain Fatty Acid Levels after Fecal Microbiota Transplantation in a Pediatric Cohort with Recurrent Clostridioides difficile Infection
    Jess, Alison T.
    Eskander, George Hany
    Vu, My H.
    Michail, Sonia
    METABOLITES, 2023, 13 (10)
  • [33] Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients
    Ali, Hiba
    Khurana, Shruti
    Ma, Weijie
    Peng, Yuanzun
    Jiang, Zhi-Dong
    DuPont, Herbert
    Zhang, Hao Chi
    Thomas, Anusha S.
    Okhuysen, Pablo
    Wang, Yinghong
    JOURNAL OF CANCER, 2021, 12 (21): : 6498 - 6506
  • [34] A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent Clostridioides difficile Infection
    Wang, Yifan
    Hunt, Aaron
    Danziger, Larry
    Drwiega, Emily N.
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [35] Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for C. difficile Infections Across Academic and Private Clinical Settings
    Dogra, Siddhant
    Oneto, Caterina
    Sherman, Alex
    Varughese, Resmi
    Yuen, Alexa
    Sherman, Isabel
    Cohen, Avi
    Luo, Yuying
    Chen, Lea Ann
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (10) : 1024 - 1030
  • [36] Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation
    Tremblay-Gravel, Maxime
    Racine, Normand
    de Denus, Simon
    Ducharme, Anique
    Pelletier, Guy B.
    Giraldeau, Genevieve
    Liszkowski, Mark
    Parent, Marie-Claude
    Carrier, Michel
    Fortier, Annik
    White, Michel
    JACC-HEART FAILURE, 2017, 5 (12) : 891 - 901
  • [37] Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in a Pediatric Heart Transplant Patient
    Flannigan, Kyle L.
    Rajbar, Taylor
    Moffat, Andrew
    McKenzie, Leanna S.
    Dicke, Frank
    Rioux, Kevin
    Workentine, Matthew L.
    Louie, Thomas J.
    Hirota, Simon A.
    Greenway, Steven C.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2017, 4
  • [38] Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection
    Mamo, Yafet
    Woodworth, Michael H.
    Wang, Tiffany
    Dhere, Tanvi
    Kraft, Colleen S.
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (11) : 1705 - 1711
  • [39] Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals?
    Vedala, Krishna
    Sobash, Philip
    Shah, Parth
    Kamoga, Gilbert-Roy
    FRONTIERS IN PUBLIC HEALTH, 2021, 9 : 670941
  • [40] Prescription Microbiome Therapeutic for Recurrent Clostridioides difficile Infection: Fecal Microbiota Live-js']jslm
    Oneto, Caterina
    Khanna, Sahil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (1S) : S16 - S21
12345